Motif Bio PLC

Motif Bio PLC
Stock Exchange Other OTC
EPS
$0.07
Market Cap
$10.27 M
Shares Outstanding
296.53 M
Public Float
276.45 M
Motif Bio PLC
Stock Exchange London Stock Exchange
EPS
GBP0.05
Market Cap
GBP7.88 M
Shares Outstanding
342.49 M
Public Float
-

Profile

Address
5 Independence Way
Princeton New Jersey 08540
United States
Employees -
Website https://www.motifbio.com/
Updated 07/08/2019
Motif Bio Plc is a clinical stage biopharmaceutical company which develops novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It pipeline of antibiotics includes iclaprim, and MTF-001, a preclinical program to design a dihydrofolate reductase inhibitor (DHFRi). The company was founded on November 20, 2014 and is headquartered in New York, NY.

Financials

View All
Created with Highcharts 5.0.14Motif Bio PLCNet Income. Fiscal year is January-December. All values GBP Thousands.5 5745 57429 88529 88534 79534 79510 48810 4882015201620172018010k20k30k40k

Graham George Lumsden
Chief Executive Officer & Executive Director
Jonathan E. Gold
Chief Financial Officer & Executive Director